| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.079 | 0.03 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | BRD-K75293299 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.03 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |